The results showed that FDX1 expression may be associated with specific different immune subtypes in ACC, BRCA, KIRP, KIRC, LIHC, LGG, PRAD (prostate adenocarcinoma), SARC, STAD, THCA and UCEC (uterine corpus endometrial carcinoma) (Fig. 5). Here, FDX1 is linked to prostate adenocarcinoma.